[PDF] [PDF] JP 3-11 Operations in Chemical Biological - Joint Chiefs of Staff





Previous PDF Next PDF



[PDF] Chemical Biological Radiological and Nuclear (CBRN) Injury

_Radiological_Nuclear_Injury_Part1_Initial_Response_01_May_2018_ID69.pdf



[PDF] ATP 3-1174 Chemical Biological Radiological and Nuclear

15 avr 2021 · ATP 3-11 74 CBRN Platoons provides CBRN platoon leaders and NCO leadership a doctrinal guideline to assess protect and mitigate CBRN threats 



[PDF] JKO LMS: ATRRS Course Approved List

17 avr 2013 · Points 1 AFR-J3OP-US850 VCAT Horn Of Africa Course CBRNE Attacks Course Course Emergency Preparedness Response Course (EPRC) -



[PDF] JP 3-11 Operations in Chemical Biological - Joint Chiefs of Staff

29 oct 2018 · Military support to emergency preparedness (EP) consists of active target areas for CBRN attack such as choke points key terrain 



[PDF] NATO STANDARD AMedP-71 MEDICAL MANAGEMENT OF CBRN

1 jui 2018 · CBRN Triage Points in the Medical Evacuation Chain interventions are focused on both pre-event preparedness (prevent and protect) and 



[PDF] Hospital Management of Chemical Biological Radiological

22 juil 2022 · The HM-CBRNE course represents an advanced level education and training Course counts for promotion points and can be placed on ERB/ORB



[PDF] Medical Support in a CBRN Contested Environment - Air University

the trainees will get appropriate preparedness to use the CBRN equipment nam War and other military actions against the US from that point on have



[PDF] JP 3-11 Operations in Chemical Biological Radiological and

29 oct 2018 · Military support to emergency preparedness (EP) consists of active target areas for CBRN attack such as choke points key terrain 



[PDF] Defining the Attributes of a CBRN Human Response Model Findings

within the Office of the Assistant Secretary for Preparedness and Response questions addressing several points pertaining to human response models and 



[PDF] wmd-cbrn-aqd-guidepdf

1 sept 2017 · Radiation surveys and Federal regulations and planning reports are also presented 1 JKO J3O P-US258-Emergency Preparedness Response Course ( 

EPAOTMENTFTHEARMY• "

UNITEDSTATSO

A

FAMERIC

RHISWE'LLDEFEND

35()$&(

PXOWLQDWLRQDO DOOLDQFH RU FRDOLWLRQ PLOLWDU\ FRPPDQG VKRXOG IROORZ PXOWLQDWLRQDO

GRFWULQH

)RUWKH&KDLUPDQRIWKH-RLQW&KLHIVRI6WDII /LHXWHQDQW*HQHUDO860& 'LUHFWRU-RLQW)RUFH'HYHORSPHQW iiiSUMMARY OF CHANGES

REVISION OF JOINT PUBLICATION 3-11

DATED 04 OCTOBER 2013

This publication was validated without change on 28 October 2020. Synchronizes and updates language in Joint Publication (JP) 3-11,Operations in Chemical, Biological, Radiological, and Nuclear Environments, with JP 3-40, Countering Weapons of Mass Destruction, and JP 3-41,Chemical, Biological,

Radiological, and Nuclear Response.

Recognizes the proponent change for global countering weapons of mass destruction operations responsibility from United States Strategic Command to United States Special Operations Command. Removes the "Prepare, Prevent, Protect, Respond, and Recover" model. Synchronizes planning discussion with JP 5-0,Joint Planning. Updates discussion on logistics and sustainment execution in chemical, biological, radiological, and nuclear (CBRN) environments. Adds discussion of CBRN operations proximate to and effects of intentional or unintentional release of hazards in urban environments. Adds discussion on information function as it relates to operations in CBRN environments. Updates toxic industrial materials and radiological hazard considerations. Adds classified appendix for nontraditional agents.

Adds, revises, or deletes numerous definitions.

,QWHQWLRQDOO\%ODQN

7$%/(2)&217(176

3$*( (;(&87,9(6800$53DUW, $EEUHYLDWLRQV$FURQ\PVDQG,QLWLDOLVPV*/

3DUW,, 7HUPVDQG'HILQLWLRQV*/

),*85( ,, +D]DUG$ZDUHQHVVDQG8QGHUVWDQGLQJLQWKH-RLQW2SHUDWLRQDO (QYLURQPHQW,, ,, -RLQW6KLS/DQG&KHPLFDO%LRORJLFDO5DGLRORJLFDODQG1XFOHDU $ &KHPLFDO$JHQW(IIHFWV$ $ &KHPLFDO:DUIDUH$JHQW&DWHJRULHV$ $ ,QGXVWULDO&KHPLFDO6LWH0LQLPXP'RZQZLQG+D]DUG6DPSOH$ % 3DWKRJHQV9LUXVHVDQG7R[LQVRI0LOLWDU\6LJQLILFDQFH% % ([DPSOHVRI%LRORJLFDO0DWHULDO9LDELOLW\% % :HDWKHU(IIHFWVRQ%LRORJLFDO$JHQW'LVVHPLQDWLRQ% & (IIHFWVRI3URPSW5DGLDWLRQ([SRVXUH& & 6RXUFHVRI5DGLDWLRQ& & 5DGLDWLRQ([SRVXUH6WDWXV&DWHJRULHV& & 6HYHULW\RI5DGLRORJLFDO7KUHDW& & 3UREDELOLW\RI5DGLRORJLFDO7KUHDW& & /HYHORI5DGLRORJLFDO5LVN& & 5HFRPPHQGHG2SHUDWLRQDO([SRVXUH*XLGDQFH/HYHOV& ' (QHUJ\'LVWULEXWLRQRI7\SLFDO1XFOHDU$LU%XUVW' ) )RUPVRI&KHPLFDO%LRORJLFDO5DGLRORJLFDODQG1XFOHDU &RQWDPLQDWLRQ) ) /HYHOVRI&KHPLFDO%LRORJLFDO5DGLRORJLFDODQG1XFOHDU 'HFRQWDPLQDWLRQ) ) 0HWKRGVRI&KHPLFDO%LRORJLFDO5DGLRORJLFDODQG1XFOHDU 'HFRQWDPLQDWLRQ) ) &OHDUDQFH$SSURYDO3URFHVV) (;(&87,9(6800$5< UHOHDVH RI WR[LF LQGXVWULDO ELRORJLFDOV WR[LF LQGXVWULDO

National Strategy

Strategic Context

Operational Context

Relation to the Joint

Functions

DIIHFWHG ZKHQ FRQGXFWLQJ RSHUDWLRQV LQ DQ DUHD ZKHUH &%51WKUHDWVRUKD]DUGVDUHSUHVHQW

Strategic and Operational

Planning

Planning Considerations

Preparation

Considerations

ZLWK RQJRLQJ SUHSDUDWLRQ DFWLYLWLHV DVVLVWV LQ WKH

SUHYHQWLRQRIQHJDWLYHHIIHFWV

Sustainment

Considerations

Hazard Awareness and

Understanding and

Situational Awareness

Protection

DQGFDQLQIOXHQFHWKHLUGHFLVLRQWRHPSOR\WKHP

Contamination Mitigation

Sustainment

Considerations

Operation Assessment

Process

,QWHQWLRQDOO\%ODQN &+$37(5,

Department

of Defense Strategy for Countering Weapons of Mass Destruction

Countering Weapons of Mass Destruction,

Chemical, Biological, Radiological, and Nuclear Response "Chemical weapons continue to pose a threat in Syria and Iraq. Damascus [government of Syria] has used chemicals against the opposition on multiple occasions since Syria joined the Chemical Weapons Convention. ISIL [Islamic State of Iraq and the Levant] has also used toxic chemicals in Iraq and Syria, including the blister agent sulfur mustard - the first time an extremist group has produced and used a chemical warfare agent in an attack since Aum Shinrikyo used sarin in Japan in 1995." RI &%51 LQFLGHQWV E\ VSUHDGLQJ PLVLQIRUPDWLRQ RU SDQLF HVSHFLDOO\LQDQXUEDQ Homeland Defense;Defense Support of Civil Authorities;Chemical,

Biological, Radiological, and Nuclear Response.

$ &%51 LQFLGHQW LV DQ\ RFFXUUHQFH LQYROYLQJ WKH HPHUJHQFHRI &%51 For further information on operations in a CBRN environment, see Field Manual (FM) 3-

11/Marine Corps Reference Publication (MCRP) 10-10E.3(Marine Corps Warfighting

Publication [MCWP] 3-37.1)/Navy Warfare Publication (NWP) 3-11/Air Force Tactics,

Techniques, and Procedures (AFTTP) 3-2.42,

National Security Strategy

Treaty on the Non-Proliferation of Nuclear Weapons

Nuclear Nonproliferation Treaty

DVVHVVPHQWV WKDW DGGUHVV DGYHUVDU\ FDSDELOLWLHV WKDW PD\ EH XVHG DJDLQVW 86 IRUFHV &%51WKUHDWVRUKD]DUGV

See JP 3-40, for more information on the

various strategic measures available to the US to neutralize an adversary's ability to employ WMD.

See JP 3-41, for more

information on the US military response to reduce the effects of a CBRN incident. For chemical, biological, radiological, nuclear, and high-yield explosives (CBRNE)- specific guidance and standards for DOD installations worldwide to use when preventing, protecting against, mitigating, responding to, and recovering from CBRNE incidents, see

Department of Defense Instruction (DODI) 3020.52,

H[HFXWHG DQG DVVHVVHG WR HQDEOH IRUFHV WR FRQWLQXH HIIHFWLYH RSHUDWLRQV LQ D &%51 For additional information on the C2 function, see JP 3-0, and Army Techniques Publication (ATP) 3-11.36/MCRP 10-10E.1(MCRP 3-37B)/Navy Tactics, Techniques, and Procedures (NTTP) 3-11.34/Air Force Tactics, Techniques, and

Procedures (Instruction) (AFTTP[I]) 3-20.70,

LQWHOOLJHQFH XVHG LQ WKH MRLQW LQWHOOLJHQFH SUHSDUDWLRQ RI WKHRSHUDWLRQDO HQYLURQPHQW

PXVWEHLQDFFRUGDQFHZLWK'2'SROLF\

See JP 2-0, and JP 2-01.3,

for additional information on intelligence aspects within a

CBRN environment.

See Department of Defense Directive (DODD) 5240.01,

DODD 3025.18, Chairman of the Joint

Chiefs of Staff Instruction (CJCSI) 3125.01,

and JP 3-28, for guidance on IAA. See JP 3-09, and JP 3-60, for additional information on fires and targeting. See JP 3-0, for additional information on movement and maneuver. See JP 3-0, and Chapter III, "Execution," for additional information on protection and aspects within a CBRN environment.

FRQVXPSWLRQDQGGHFRQWDPLQDWLRQ

See JP 4-0, and JP 4-02, for additional information on sustainment aspects within a CBRN environment. ,QWHQWLRQDOO\%ODQN &+$37(5,, :0'WRLQFOXGH&%51GHIHQVHDQG&%51UHVSRQVH For additional information on IEDs, see JP 3-15.1,

See JP 3-25, for additional information on

countering improvised weapon networks.

See JP 2-01, for additional

information on exploitation support to counter threat networks. For additional information on JIPOE, see JP 2-01.3, IDFWRUV DQG HFRQRPLF FKDUDFWHULVWLFV RI WKH 2( DVVXPH LQFUHDVHG LPSRUWDQFH IRU LQWHUYHQWLRQ E\ WKLUGSDUW\ FRXQWULHV DQG QRQVWDWH DFWRUV DOOZHLJKHGDJDLQVW86 E

UHJDUGLQJGHSOR\PHQWRI&%51ZHDSRQV

L&DSDELOLWLHV IRU IRUFH SURWHFWLRQ )3 DQG SURWHFWLRQ RIWKH FLYLOLDQ

SRSXODWLRQDQGLQIUDVWUXFWXUH

D &%51 UHFRQQDLVVDQFH HOHPHQWV REVHUYHG ZLWK FRQYHQWLRQDO

UHFRQQDLVVDQFHXQLWV

&%51GHFRQWDPLQDWLRQHOHPHQWVPRYHGIRUZDUG G &%51ZDUQLQJVVLJQDOVWRHQHP\WURRSV &%51ZHDSRQVZLWKLQUDQJHRIIULHQGO\IRUFHV E &RQGXFW DVVHVVPHQWV WKUHDWYXOQHUDELOLW\ SUHYLRXVLQFLGHQWSDVWXVH

LPSDFWKD]DUGSUHGLFWLRQPRGHOLQJ

&RRUGLQDWH XQLW SURWHFWLRQ PHDVXUHV HVSHFLDOO\ LQGLYLGXDO SURWHFWLYH

DQGSURFHGXUHV

KD]DUGVDQGORFDWLRQV

PXOWLQDWLRQDOSDUWQHUVDQGWKH+1LQWRWKHSODQ

LQFLGHQWV

SUHSDUHGWRRSHUDWHLQ&%51HQYLURQPHQWV

DQGGHFLVLRQPDNLQJSURFHVVHV

F,Q DGGLWLRQ WR IULHQGO\ IRUFH FRQVLGHUDWLRQV FRPPDQGHUV DQG SODQQHUV VKRXOG See JP 3-06, for additional information on impacts of CBRN threats in an urban environment.

VXSSRUWLQWHJUDWLRQFHOO

See JP 4-10, and Chairman of the Joint Chiefs of Staff (CJCS) Manual 4301.01, for additional information.

See JP 3-41, for additional

information on CBRN response and JP 3-40, for additional information on CWMD operations. &%51GHIHQVHHIIRUW D SDUWLFXODUO\ LPSRUWDQW SUHUHTXLVLWH IRU PLOLWDU\ VXFFHVV GXULQJ H[HFXWLRQ RI D MRLQW

PRUHHIIHFWLYHGHFLVLRQPDNLQJ

DFWLRQV

For additional information on red teams, see JP 5-0,

See JP 2-01, for more

information.

IRULQIRUPDWLRQDUHVDWLVILHG

IRUFH WR SHUPLW PDQHXYHU DYRLGDQFH RI KD]DUG ORFDWLRQV RSHUDWLRQV LQ VWDEOH

HQYLURQPHQWVDQGVXSSRUWSODQQLQJ

KD]DUGFKDUDFWHUL]DWLRQFDSDELOLWLHV

For detailed information on tactical execution considerations, refer to ATP 3-11.37/MCRP

10-10E.7(MCRP 3-37.4)/NTTP 3-11.29/AFTTP 3-2.44,

7KH &%51 YXOQHUDELOLW\ DVVHVVPHQW FRPSLOHV WKH RWKHU W\SHVRI

7KH&%51YXOQHUDELOLW\DVVHVVPHQWZLOO

D,GHQWLI\YXOQHUDELOLWLHV

DQGSD\RII

F3UHGLFW WKH SRWHQWLDO LPSDFW WR WKH RSHUDWLRQDO DUHD LI WKH

YXOQHUDELOLW\LVH[SORLWHG

ZLWK XQLW YXOQHUDELOLWLHV WR GHWHUPLQH WKH HIIRUWV QHFHVVDU\ WR VDIHO\ PHHW LQFLGHQW JXLGDQFH WKURXJK D ULVN PDQDJHPHQW SURFHVV WR SULRULWL]H WKH LPSOHPHQWDWLRQ RI

YXOQHUDELOLW\UHGXFWLRQPHDVXUHV

ATP 3-11.36/MCRP 10-10E.1(MCRP 3-37B)/NTTP 3-11.34/AFTTP(I) 3-2.70, discusses CBRN vulnerability assessments in more detail. PDNH HYHU\ HIIRUW ZLWKLQ WKHLU DXWKRULW\ WR SUHYHQW WKH DGYHUVDU\ IURP VXFFHVVIXOO\ LQFOXGHPXOWLSOHOLQHVRIHIIRUWDQGDUHIXUWKHUGLVFXVVHGLQ-3Countering Weapon of

Mass Destruction.

For more detailed information about preventing adversary CBRN weapons employment, see JP 3-01, JP 3-03, JP 3-40,

JP 3-09.3, JP 3-0,

JP 3-25, and JP 3-60,

G J

DOD Emergency Management (EM)

Program,

DODI 6055.17, addresses requirements

(including CBRN/hazardous materials) for responders within DOD. F7DUJHWLQJ FKHPLFDO ELRORJLFDO RU QXFOHDU IDFLOLWLHV DV D SDUW RI

UHTXLUHPHQWV

For additional information on CBRN targeting, see JP 3-40, . For additional guidance on offensive actions against WMD-related targets, see JP 3-05 JP 3-09, JP 3-60, and

DODD S-2060.04,

DFWLYLWLHV UHTXLUH MRLQW PXOWLQDWLRQDO DQG LQWHUDJHQF\ FRRUGLQDWLRQ IRU DFWLYLWLHV WKDW VXSSRUW &%51 DZDUHQHVV DQG XQGHUVWDQGLQJ SURWHFWLRQ RI FULWLFDO DVVHWV DQG

FRQWDPLQDWLRQPLWLJDWLRQPHDVXUHV

KD]DUGV"

:KDW IULHQGO\ RSHUDWLRQV PD\ EH WKH VRXUFH RI FROODWHUDO &%51

KD]DUGV"

RSHUDWLRQDODUHD"

GRQRWDOUHDG\H[LVWWKHUH"

KD]DUGV"

E&RQVLGHUDWLRQVIRUKD]DUGXQGHUVWDQGLQJ

FXUUHQWRSHUDWLRQV"

IXWXUHRSHUDWLRQV"

LQD&%51HQYLURQPHQW"

'RDQ\SODQQLQJDVVXPSWLRQVKDYHWREHFKDQJHG"

YLDEOHSUREOHPVROXWLRQV"

:KDWWLPHOLQHVZLOOQHHGWREHFKDQJHG" :KDWSKDVLQJFKDQJHVZLOOEHUHTXLUHG" :KDW PHGLFDO WUHDWPHQWV PD\ EH QHHGHG WR UHFRQVWLWXWH WKH

RSHUDWLRQDOIRUFHV"

LQFOXGH WKRVH WKDW UHGXFH WKH YXOQHUDELOLW\ RI FULWLFDO UHVRXUFHV LQFOXGLQJ SHUVRQQHO

HIIHFWV

D%DVLF REMHFWLYHV IRU RSHUDWLRQV DQG FDPSDLJQV LQFOXGH UDSLG DQG

ODZRIZDU

E0LVVLRQRULHQWHG SURWHFWLYH SRVWXUH 0233 LV D IOH[LEOH V\VWHP RI JHDU UHTXLUHG LQ WKHLU SDUWLFXODU VLWXDWLRQV DQG VWLOO PDLQWDLQ FRPEDW HIIHFWLYHQHVV GHWHFWLRQ LQGLYLGXDO SURWHFWLRQ&2/352 DQG GHFRQWDPLQDWLRQ DFWLRQV ZKLOH ODQG

0233IRFXVHVRQLQGLYLGXDOSURWHFWLRQ

For more information on MOPP system flexibility, see ATP 3-11.32/MCRP 10-

10E.8/NTTP 3-11.37,

and NTTP/Coast Guard TTP 3-

20.31,

L For further guidance on communications related to CBRN incidents, see Presidential

Policy Directive (PPD)-25,

For further details on public affairs, see JP 3-61, E

For further planning considerations, see JP 3-28,

and CJCSI 3125.01, &ROOHFWDQGDQDO\]H&%51WKUHDWDQGKD]DUGGDWD

0RQLWRU ERWK DGYHUVDU\ DQGMRLQW IRUFH SUHSDUDWLRQ DFWLYLWLHV DQG UHYLVH

DVVHVVPHQWV

DJDLQVW&%51ZHDSRQV

SDUWQHUV

0RQLWRU IRUFHV DQG IDFLOLWLHV WR HQVXUH SUHSDUDWLRQ WR RSHUDWH LQ &%51

HQYLURQPHQWV

6SHFLILF DFWLYLWLHV WR HQKDQFH KD]DUG DZDUHQHVV XQGHUVWDQGLQJ GXULQJ

LQ LQIRUPDWLRQ JDSV UHILQH SRWHQWLDO WKUHDWV DQG KD]DUGV GDWDLQWR IDFWV YDOLGDWH

DVVXPSWLRQVDQGILQDOL]HWKHSODQ

WR DVVHVV LWV LPSDFW RQ RSHUDWLRQV DQG SURWHFWLRQ 7KH DVVHVVPHQW PD\ OHDG WR GLUHFWLYHVRUGHUV WR KHOS SURWHFW DJDLQVW WKH HIIHFWV RI WKH DVVHVVHG &%51 KD]DUG WRHQVXUHWKH\DUHUHDG\WRUHVSRQG 6RPH VLWXDWLRQV UHTXLUH XQLTXH DSSOLFDWLRQ RI GHFRQWDPLQDWLRQ RI VWUDWHJLFDOO\ VLJQLILFDQW DUHDVWHUUDLQ RU IDFLOLWLHV 2WKHU IDFWRUV UHTXLULQJ FRQVLGHUDWLRQ LQFOXGH VWDQGLQJ XSGHDFWLYDWLQJ D WDVN IRUFH VHOHFWLQJ DQG For additional decontamination considerations, see Appendix F, "Contamination

Mitigation Considerations."

For specific information on tactical decontamination operations and levels, see ATP 3-

11.32/MCRP 10-10E.8/NTTP 3-11.37,

G For more information on health support services, refer to JP 4-02, DQRWKHU 3ODQV VKRXOG DOORZ IRU VXUJHV LQ ORJLVWLFV UHTXLUHPHQWV IRU &%51 GHIHQVH See Appendix F, "Contamination Mitigation Considerations," for additional decontamination considerations. ,QWHQWLRQDOO\%ODQN &+$37(5,,, DQG 62) RUJDQL]DWLRQV DQG FDSDELOLWLHV WR IXQFWLRQ JHQHUDOO\ DVWKH\ZHUHGHVLJQHG OHDGHUVKLS WR PD[LPL]H RSHUDWLRQDO SHUIRUPDQFH DQG RYHUFRPH WKH DPELJXLWLHV DQG XQFHUWDLQWLHV LQKHUHQW LQ FRPEDW RSHUDWLRQV HVSHFLDOO\ ZKHQ IDFHG ZLWK D &%51

HQYLURQPHQW

For detailed information on tactical execution considerations, refer to FM 3-11/MCRP 10-

10E.3(MCWP 3-37.1)/NWP 3-11/AFTTP 3-2.42,

, and ATP 3-05.11, For a more detailed discussion of creating shared understanding, see JP 3-0, -)& SURFHVVHV WKLV DZDUHQHVV RI D &%51 LQFLGHQW WR JDLQ DQ XQGHUVWDQGLQJ RI LWV

LPSOLFDWLRQVWRMRLQWRSHUDWLRQV

For more information on CBRN warning and reporting, refer to ATP 3-11.32/MCRP 10-

10E.8/NTTP 3-11.37,

For more information to safeguard the force and manage response, see JP 3-40, and JP 3-41, respectively. For more information on decontamination activities and levels, see ATP 3-11.32/MCRP

10-10E.8/NTTP 3-11.37,

IRUIRUFHJHQHUDWLRQDQGVXVWDLQPHQW

PDUNLQJ LV UHTXLUHG 3HUVRQQHO FRQGXFW VHOIDVVHVVPHQW DFWLYLWLHV WR GHWHFW SRVVLEOH &%51FRQWDPLQDWLRQLQWKH2( For more information, refer to ATP 3-11.37/MCRP10-10E.7(MCWP 3-37.4)/NTTP 3-

11.29/AFTTP 3-2.44,

0LWLJDWLQJ&%51WKUHDWVWRPHGLFDOXQLWV

5HFRQVWLWXWLQJPHGLFDOORJLVWLFVQHWZRUNV

LQWKHRSHUDWLRQDODUHD

For more information, refer to JP 4-02,

SULQFLSOHV RI WLPH GLVWDQFH DQG VKLHOGLQJ &RPPDQGHUV VKRXOG PLQLPL]H WKH WLPH HQFDSVXODWLRQ RU JHQHWLF HQJLQHHULQJ PD\ SURWHFW DJHQWV IURP QDWXUDO GHWHULRUDWLRQ

LQFUHDVLQJWKHLUSHUVLVWHQF\

IRUHLJQ DQG GRPHVWLF ULVNV DQG SROLWLFDOHQYLURQPHQWDO VHQVLWLYLWLHV 7KH DSSURYDO WKH *&& 7KH DSSURSULDWH -0$2 GLUHFWV DQG FRQWUROV VXEVHTXHQWGLVLQWHUPHQW

7HPSRUDU\ LQWHUPHQWV UHTXLUH GHGLFDWHG WUDQVSRUWDWLRQ DVVHWV WR DYRLG WKH VSUHDG RI

For joint doctrine for handling contaminated human remains, see JP 4-06, ,QWHQWLRQDOO\%ODQN &+$37(5,9 G'XULQJ H[HFXWLRQ WKH VWDII PRQLWRUV DQG HYDOXDWHV WKH SURJUHVV RI FXUUHQW H7KH VWDII VKRXOG PRQLWRU DQG HYDOXDWH WKH IROORZLQJ DVSHFWV RI WKH &%51

HQYLURQPHQWDVSDUWRIWKHDVVHVVPHQWSURFHVV

&KDQJHVWR&%51WKUHDWVDQGKD]DUGV &KDQJHVLQ&%51IRUFHYXOQHUDELOLWLHV &KDQJHVWRXQLWFDSDELOLWLHV

6WDIIDQGFRPPDQGHUHVWLPDWHV

&%51UHVRXUFHDOORFDWLRQV ,QFUHDVHGULVNV

6XSSRUWLQJHIIRUWV

For additional information on the operation assessment process, see JP 5-0, $33(1',;$ FKHPLFDO FORXGV +RZHYHU WKH DGYHUVDU\ PD\ EH DEOH WR OHYHUDJH WKHVH IDFWRUV WR

DQGPDWHULDO

H0RVW ZHDWKHU FRQGLWLRQV GRQRW DIIHFW WKH TXDQWLW\ RI PXQLWLRQV QHHGHG IRU I7KH 1DWLRQDO &RXQWHULQJ :HDSRQV RI 0DVV 'HVWUXFWLRQ 7HFKQLFDO 5HDFKEDFN

Emergency Response Guidebook

SURYLGHWKHULVNVSUHVHQWHGE\7,&LQDQ2(

For detailed information on these and other TIC hazards, see the National Institute for

Occupational Safety and Health the US Department

of Transportation Emergency Response Guide, at http://toxnet.nlm.nih.gov/.

Emergency Response Guidebook

For more information on NTAs and their characteristics, planning considerations, and mitigation, refer to Appendix E, "Nontraditional Agent Hazard Considerations." ,QWHQWLRQDOO\%ODQN $33(1',;%

Streptococcus pneumoniae

Disease

(Etiological Agent)Untreated

Mortality (%)Medical TreatmentIncubation

Period

Communicability

(Human to Human)

Exposure

Routes

I: 99

C: 5-20In: 25-75

I: 99

V: 60 < 1

I: 30-60

C,V,In: 10-25

30

I: 35, V: 10

I: >75, V: 50-75

I: 40, V: 10

50
25-90
15-50 10-40 <1

I: >60

In: 10-50

I: >50In: < 30

< 1

10-60Vaccine

Antibiotics

Antibiotics

Antibiotics

Investigative vaccine

Antibiotics

Investigative vaccine

Vaccine

Investigative vaccine

Antiviral drugs

Investigative vaccine

Antiviral drugs

Supportive Care

Antitoxin

Supportive Care

Supportive Care

Supportive Care1-6 days

1-6 days

2-10 days

3-5 days

(1-21 days)

7-17 days

2-6 days

5-15 days

4-10 days

2-21 days

5-10 days

quotesdbs_dbs12.pdfusesText_18
[PDF] amedd courses

[PDF] ameli a vital record

[PDF] ameli étranger contact

[PDF] ameli étudiant étranger

[PDF] ameli fr application

[PDF] amelia

[PDF] amelia animal crossing

[PDF] amelia ballet ouest

[PDF] amelia bedelia

[PDF] amelia island

[PDF] amelie etudiants etrangers

[PDF] amelie fnp review course

[PDF] amelie musical review broadway

[PDF] amelie musical review dublin

[PDF] amelie musical review london